Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7.
Misiak M, Heldt M, Szeligowska M, Mazzini S, Scaglioni L, Grabe GJ, Serocki M, Lica J, Switalska M, Wietrzyk J, Beretta GL, Perego P, Zietkowski D, Baginski M, Borowski E, Skladanowski A.
Misiak M, et al. Among authors: borowski e.
Oncotarget. 2017 Oct 10;8(62):105137-105154. doi: 10.18632/oncotarget.21806. eCollection 2017 Dec 1.
Oncotarget. 2017.
PMID: 29285240
Free PMC article.